Author

Glen Collins

Observed name: Glen D. Collins

Observed institutions: Concord Hospital, Concord Repatriation General Hospital, Sydney Local Health District

OpenAlex ID: A5104293934

Medication non-adherence in inflammatory bowel diseases is associated with disability

2018 · Jonathan Perry, Andy Chen, et al. · Intestinal Research · 65

Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases

2013 · Payal Saxena, Guang Chen, et al. · Expert Opinion on Biological Therapy · 15

Research topic: Health economics of biological agents in Australia

2016 · Li‐Chin Wang, Glen Collins, et al. · Journal of Gastroenterology and Hepatology · 2

Surgical resection rate of Crohn's disease over time: the Sydney Inflammatory Bowel Disease Cohort (1942-2012)

2012 · Viraj C. Kariyawasam, Rosy Wang, et al. · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · 1

An inflammatory bowel disease clinical pharmacist significantly improves medication acceptance rates through personalised counselling

2012 · Jenny Chan, Christian P. Selinger, et al. · 1

Mo1846 DEVELOPMENT OF SIMPLIFIED SCORING SYSTEM TO PREDICT TWO-YEAR CLINICAL REMISSION OF PATIENTS WITH ULCERATIVE COLITIS AFTER TREATMENT WITH VEDOLIZUMAB

2024 · Thanaboon Chaemsupaphan, Aviv Pudipeddi, et al. · Gastroenterology

Organising infusions: Application administration and complications

2016 · Glen Collins · Journal of Gastroenterology and Hepatology

Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis

2015 · Jo-Hua Chen, Crispin J. Corte, et al. · Gastroenterology

Comparative analysis of suspected unexpected serious adverse reactions reported in inflammatory bowel disease biological agents trials

2012 · Tissa A. Tandiari, Ji Ae Yoon, et al. · Journal of Gastroenterology and Hepatology

Works count: 9

Citation count: 84

H-index: 2

I10-index: 2